Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial) (ACTIVE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Dr. Alexander Kulik, Boca Raton Regional Hospital
ClinicalTrials.gov Identifier:
NCT01528709
First received: February 6, 2012
Last updated: July 18, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)